HYUNDAI BIOLAND Co.Ltd (052260) - Total Liabilities

Latest as of September 2025: ₩27.91 Billion KRW ≈ $18.91 Million USD

Based on the latest financial reports, HYUNDAI BIOLAND Co.Ltd (052260) has total liabilities worth ₩27.91 Billion KRW (≈ $18.91 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore HYUNDAI BIOLAND Co.Ltd net asset momentum to track the company's year-over-year net asset growth rate.

HYUNDAI BIOLAND Co.Ltd - Total Liabilities Trend (2011–2024)

This chart illustrates how HYUNDAI BIOLAND Co.Ltd's total liabilities have evolved over time, based on quarterly financial data. See HYUNDAI BIOLAND Co.Ltd (052260) free cash flow to measure how efficiently the company converts operating cash flow to free cash.

HYUNDAI BIOLAND Co.Ltd Competitors by Total Liabilities

The table below lists competitors of HYUNDAI BIOLAND Co.Ltd ranked by their total liabilities.

Company Country Total Liabilities
Ferroamp Elektronik AB
ST:FERRO
Sweden Skr78.55 Million
Dental Corporation Public Company Limited
BK:D
Thailand ฿520.10 Million
Myomo Inc
NYSE MKT:MYO
USA $27.75 Million
Metrod Holdings Bhd
KLSE:6149
Malaysia RM1.57 Billion
Canterra Minerals Corporation
V:CTM
Canada CA$1.41 Million
Kutcho Copper Corp
V:KC
Canada CA$31.23 Million
OnKure Therapeutics, Inc.
NASDAQ:OKUR
USA $6.41 Million
Zhong An Group Limited
F:35Z
Germany €17.98 Billion

Liability Composition Analysis (2011–2024)

This chart breaks down HYUNDAI BIOLAND Co.Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 052260 market cap.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 3.51 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.20 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.17 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how HYUNDAI BIOLAND Co.Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for HYUNDAI BIOLAND Co.Ltd (2011–2024)

The table below shows the annual total liabilities of HYUNDAI BIOLAND Co.Ltd from 2011 to 2024.

Year Total Liabilities Change
2024-12-31 ₩56.72 Billion
≈ $38.44 Million
+17.95%
2023-12-31 ₩48.08 Billion
≈ $32.59 Million
+2.72%
2022-12-31 ₩46.81 Billion
≈ $31.72 Million
-1.23%
2021-12-31 ₩47.39 Billion
≈ $32.12 Million
-6.02%
2020-12-31 ₩50.43 Billion
≈ $34.18 Million
-5.44%
2019-12-31 ₩53.33 Billion
≈ $36.14 Million
+20.50%
2018-12-31 ₩44.26 Billion
≈ $29.99 Million
+14.79%
2017-12-31 ₩38.55 Billion
≈ $26.13 Million
+3.82%
2016-12-31 ₩37.14 Billion
≈ $25.17 Million
+17.71%
2015-12-31 ₩31.55 Billion
≈ $21.38 Million
+10.00%
2014-12-31 ₩28.68 Billion
≈ $19.44 Million
-18.36%
2013-12-31 ₩35.13 Billion
≈ $23.81 Million
-24.31%
2012-12-31 ₩46.41 Billion
≈ $31.45 Million
+30.49%
2011-12-31 ₩35.56 Billion
≈ $24.10 Million
--

About HYUNDAI BIOLAND Co.Ltd

KQ:052260 Korea Personal & Household Products & Services
Market Cap
$32.83 Million
₩48.45 Billion KRW
Market Cap Rank
#23383 Global
#1547 in Korea
Share Price
₩3230.00
Change (1 day)
+0.00%
52-Week Range
₩3225.00 - ₩5230.00
All Time High
₩21553.60
About

HYUNDAI BIOLAND Co.,Ltd manufactures and sells raw materials for cosmetics, nutraceuticals, and regenerative medicines. It offers anti-aging, moisturizing, whitening, skin protection, and other cosmetic ingredients; functional food ingredients and general food raw materials; and active pharmaceutical ingredients. The company was formerly known as SKbioland Co., Ltd. and changed its name to HYUNDA… Read more